BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 17827356)

  • 21. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
    Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
    Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
    Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
    Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
    Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
    Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
    Nkhoma S; Molyneux M; Ward S
    Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
    Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
    Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
    J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.
    Beavogui AH; Djimde AA; Gregson A; Toure AM; Dao A; Coulibaly B; Ouologuem D; Fofana B; Sacko A; Tekete M; Kone A; Niare O; Wele M; Plowe CV; Picot S; Doumbo OK
    Int J Parasitol; 2010 Aug; 40(10):1213-20. PubMed ID: 20460125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of area under the curve to characterize transmission potential after antimalarial treatment.
    Méndez F; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2006 Oct; 75(4):640-4. PubMed ID: 17038686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
    Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
    Méndez F; Muñoz A; Carrasquilla G; Jurado D; Arévalo-Herrera M; Cortese JF; Plowe CV
    Am J Epidemiol; 2002 Aug; 156(3):230-8. PubMed ID: 12142257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
    Biswas S
    Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.